(2022). Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations. In Health and Social Care Delivery Research . http://doi.org/10.3310/kodq0769.
(2023). Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study. Bmc Musculoskelet Disord, 24, 106. http://doi.org/10.1186/s12891-023-06190-7.
(2022). Primary care consultations and pain medicine prescriptions: a comparison between patients with and without chronic pain after total knee replacement. Bmc Musculoskelet Disord, 23, 548. http://doi.org/10.1186/s12891-022-05492-6.
(2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771.
(2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9.